Premium Nahrungsergänzungsmittel | artgerecht

Sudan Ebolavirus (SUDV): Symptoms, Transmission and Treatment

Sudan ebolavirus (SUDV) is a highly dangerous pathogen of the family Filoviridae that causes severe viral hemorrhagic fever with a high case fatality rate.

Regular tips about health Regular tips about health

Things worth knowing about "Sudan ebolavirus"

Sudan ebolavirus (SUDV) is a highly dangerous pathogen of the family Filoviridae that causes severe viral hemorrhagic fever with a high case fatality rate.

What is Sudan Ebolavirus?

Sudan ebolavirus (SUDV) is one of several species within the genus Orthoebolavirus, belonging to the family Filoviridae. It is one of the causative agents of Ebola virus disease (EVD), a life-threatening viral hemorrhagic fever. The virus was first identified in 1976 during an outbreak in Sudan (now South Sudan), occurring simultaneously with the first known Zaire ebolavirus outbreak in what was then Zaire. Since then, Sudan ebolavirus has been responsible for several additional outbreaks in East Africa, including a significant outbreak in Uganda in 2022.

Causes and Transmission

Sudan ebolavirus is transmitted through direct contact with the body fluids of infected individuals or animals, including blood, saliva, sweat, urine, vomit, and other secretions. Airborne transmission has not been documented. Fruit bats are considered the most likely natural reservoir, although this has not been conclusively confirmed for SUDV. Zoonotic transmission from animals to humans is possible. Within healthcare settings and households, the virus can spread rapidly if infection control measures are inadequate.

Symptoms

The incubation period typically ranges from 2 to 21 days. The illness usually begins abruptly with:

High fever
Severe headache
Muscle and joint pain
General weakness and fatigue
Nausea, vomiting, and diarrhea
Abdominal pain

As the disease progresses, more severe symptoms may develop, including:

Hemorrhagic manifestations (internal and external bleeding)
Liver and kidney failure
Multi-organ failure
Shock

The case fatality rate for Sudan ebolavirus ranges between 41 and 65 percent depending on the outbreak, making it slightly lower than Zaire ebolavirus but still extremely high.

Diagnosis

Diagnosing a Sudan ebolavirus infection requires specialized laboratory testing under the highest biosafety conditions (BSL-4). The following methods are used:

RT-PCR (Reverse Transcription Polymerase Chain Reaction): Detection of viral RNA in blood; considered the gold standard
ELISA (Enzyme-Linked Immunosorbent Assay): Detection of viral antigens or specific antibodies
Electron microscopy: Direct visualization of the virus in samples
Virus isolation: Culturing the virus under BSL-4 conditions

Clinical diagnosis alone is insufficient due to the overlap of symptoms with other diseases such as malaria and typhoid fever.

Treatment

As of today, there is no specifically approved antiviral treatment for Sudan ebolavirus. Management is primarily supportive:

Intravenous fluid replacement to compensate for fluid losses
Correction of electrolyte imbalances
Supplemental oxygen when needed
Medications to manage blood pressure and pain
Treatment of secondary infections

Unlike Zaire ebolavirus, the monoclonal antibodies approved for ZEBOV (e.g., Atoltivimab/Maftivimab/Odesivimab or Ansuvimab) are not effective against SUDV, as these antibodies target the Zaire-specific glycoprotein. Vaccine candidates and antiviral therapeutics specifically targeting Sudan ebolavirus are currently under development and being tested in clinical trials.

Prevention and Infection Control

Since no approved SUDV-specific vaccine is currently available (as of 2024, candidates remain in clinical trials), prevention relies on:

Personal protective equipment (PPE) for healthcare workers (gloves, protective clothing, masks, face shields)
Isolation of infected individuals
Safe burial practices for deceased individuals (avoiding direct contact with remains)
Community education about transmission routes and preventive behaviors

Contact tracing

References

World Health Organization (WHO): Ebola virus disease - Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease (2023)
Feldmann H, Geisbert TW: Ebola haemorrhagic fever. Lancet. 2011;377(9768):849-862. doi:10.1016/S0140-6736(10)60667-8
Centers for Disease Control and Prevention (CDC): Sudan Ebolavirus. https://www.cdc.gov/vhf/ebola/resources/virus-ecology.html (2023)

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.